Scan to download
BTC $67,993.00 -0.46%
ETH $1,967.97 +0.74%
BNB $621.25 +1.46%
XRP $1.47 +1.51%
SOL $85.67 +0.91%
TRX $0.2839 +1.36%
DOGE $0.0993 -2.17%
ADA $0.2843 +2.23%
BCH $561.13 +0.24%
LINK $8.81 +1.31%
HYPE $30.24 +1.95%
AAVE $124.19 -0.66%
SUI $0.9704 +0.87%
XLM $0.1671 -0.65%
ZEC $287.73 +0.69%
BTC $67,993.00 -0.46%
ETH $1,967.97 +0.74%
BNB $621.25 +1.46%
XRP $1.47 +1.51%
SOL $85.67 +0.91%
TRX $0.2839 +1.36%
DOGE $0.0993 -2.17%
ADA $0.2843 +2.23%
BCH $561.13 +0.24%
LINK $8.81 +1.31%
HYPE $30.24 +1.95%
AAVE $124.19 -0.66%
SUI $0.9704 +0.87%
XLM $0.1671 -0.65%
ZEC $287.73 +0.69%

The judge ruled that Bitfarms must immediately terminate its "poison pill" strategy aimed at opposing Riot Platforms' acquisition

2024-07-25 13:58:35
Collection

ChainCatcher news, the encrypted mining company Riot Platforms stated in a declaration on July 24 that the Ontario Capital Markets Tribunal issued a cease trading order on Bitfarms' poison pill plan, immediately terminating the strategy.

Since June 13, Bitfarms has been opposing Riot Platforms' $950 million acquisition offer, claiming that Riot unfairly undervalued the company. The company adopted a poison pill strategy known as a "rights plan" to attempt to block the acquisition.

Poison pill strategies are typically used by companies to prevent hostile takeovers. Under this strategy, existing shareholders purchase additional shares at a significant discount, diluting the value of the shares held by the acquirer. According to Bitfarms' now-defunct rights plan, if any entity acquires more than 15% of the company's outstanding shares before September 10, Bitfarms will issue new shares to other existing shareholders, thereby reducing that entity's ownership.

app_icon
ChainCatcher Building the Web3 world with innovations.